SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001851734-22-000577
Filing Date
2022-09-30
Accepted
2022-09-30 16:35:20
Documents
13
Period of Report
2022-09-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20220930_8k.htm   iXBRL 8-K 60687
  Complete submission text file 0001851734-22-000577.txt   187040

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA noticker-20220929.xsd EX-101.SCH 3633
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20220929_def.xml EX-101.DEF 10848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20220929_lab.xml EX-101.LAB 14480
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20220929_pre.xml EX-101.PRE 10894
7 EXTRACTED XBRL INSTANCE DOCUMENT arch20220930_8k_htm.xml XML 2415
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 221284548
SIC: 3841 Surgical & Medical Instruments & Apparatus